Isidro Palos

9PUBLICATIONS
22CO-AUTHORS
Biologically active moleculesBioremediationMedical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Medical parasitology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 26, 2026
Biological Evaluation of Esters of 4-Carboxylate-1,2,3-triazine and Analogs as New Potential Anti-<i>Mycobacterium tuberculosis</i> Agents.

|Dec 28, 2024
Phenanthrene degradation by <i>Bacillus cereus</i> strain Sneb1168 isolated from Reynosa, Mexico.

Timoteo Delgado-Maldonado, Fabián Martínez-Infante, Isidro Palos

|Oct 16, 2024
Quinoxaline 1,4-di-<i>N</i>-oxide Derivatives as New Antinocardial Agents.

Isidro Palos, Alonzo González-González, Alma D Paz-González

|Aug 16, 2024
Expanding the chemical space of ester of quinoxaline-7-carboxylate 1,4-di-<i>N</i>-oxide derivatives as potential antitubercular agents.

Alonzo González-González, Oscar Sánchez-Sánchez, Baojie Wan

|Mar 29, 2023
Virtual Screening of Benzimidazole Derivatives as Potential Triose Phosphate Isomerase Inhibitors with Biological Activity against <i>Leishmania mexicana</i>.

Lenci K Vázquez-Jiménez, Alfredo Juárez-Saldivar, Manuel J Chan-Bacab

|Sep 09, 2022
Ligand-Based Virtual Screening and Molecular Docking of Benzimidazoles as Potential Inhibitors of Triosephosphate Isomerase Identified New Trypanocidal Agents.

Lenci K Vázquez-Jiménez, Alfredo Juárez-Saldivar, Rogelio Gómez-Escobedo

Pageof 2

Frequent Collaborators

8 joint publications

Gildardo Rivera

3 joint publications

Eyra Ortiz-Pérez

3 joint publications

Ana Verónica Martínez-Vázquez

2 joint publications

Alma D Paz-González